Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
31 Jul 2025
// BIOSPACE
https://www.biospace.com/drug-development/biogen-eisais-leqembi-slows-alzheimers-progression-through-4-years-of-treatment
31 Jul 2025
// BIOSPACE
https://www.biospace.com/business/biogens-leqembi-push-getting-easier-as-ceo-eyes-early-stage-pipeline-restock
31 Jul 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/biogen-ticks-sales-outlook-leqembi-awaits-fda-decision-new-dosing-option
30 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/early-alzheimers-patients-continue-to-benefit-from-four-years-of-leqembi-lecanemab-irmb-therapy-new-clinical-data-presented-at-aaic-302516704.html
25 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/25/3121730/0/en/ZURZUVAE-zuranolone-Receives-Positive-Opinion-from-CHMP-for-the-Treatment-of-Women-with-Postpartum-Depression.html
22 Jul 2025
// FIERCE PHARMA
https://www.fiercepharma.com/manufacturing/biogen-ups-its-ante-north-carolina-pledging-2b-manufacturing-investment
Inspections and registrations
ABOUT THIS PAGE
Biogen is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of HUMANIZED MONOCLONAL ANTIBODY (IDEC-131) (CHO CELLS, IDEC) TO CD40L (CD 154) bulk offered by Biogen
Find a price of IDEC-114 (GALIXIMAB);CHEMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY TO CD80 (B7.1) bulk offered by Biogen
Find a price of MURINE MONOCLONAL ANTIBODY (2B8) TO CD20 bulk offered by Biogen